BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 33723244)

  • 1. Rewiring of purine metabolism in response to acidosis stress in glioma stem cells.
    Xu X; Wang L; Zang Q; Li S; Li L; Wang Z; He J; Qiang B; Han W; Zhang R; Peng X; Abliz Z
    Cell Death Dis; 2021 Mar; 12(3):277. PubMed ID: 33723244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acidosis enhances the self-renewal and mitochondrial respiration of stem cell-like glioma cells through CYP24A1-mediated reduction of vitamin D.
    Hu P; Li S; Tian N; Wu F; Hu Y; Li D; Qi Y; Wei Z; Wei Q; Li Y; Yin B; Jiang T; Yuan J; Qiang B; Han W; Peng X
    Cell Death Dis; 2019 Jan; 10(1):25. PubMed ID: 30631035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acidic stress promotes a glioma stem cell phenotype.
    Hjelmeland AB; Wu Q; Heddleston JM; Choudhary GS; MacSwords J; Lathia JD; McLendon R; Lindner D; Sloan A; Rich JN
    Cell Death Differ; 2011 May; 18(5):829-40. PubMed ID: 21127501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ALKBH5 Promotes the Proliferation of Glioma Cells via Enhancing the mRNA Stability of G6PD.
    Liu Z; Chen Y; Wang L; Ji S
    Neurochem Res; 2021 Nov; 46(11):3003-3011. PubMed ID: 34297301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-30a suppresses self-renewal and tumorigenicity of glioma stem cells by blocking the NT5E-dependent Akt signaling pathway.
    Peng L; Ming Y; Zhang L; Zhou J; Xiang W; Zeng S; He H; Chen L
    FASEB J; 2020 Apr; 34(4):5128-5143. PubMed ID: 32067282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting metabolic plasticity in glioma stem cells in vitro and in vivo through specific inhibition of c-Src by TAT-Cx43
    Pelaz SG; Jaraíz-Rodríguez M; Álvarez-Vázquez A; Talaverón R; García-Vicente L; Flores-Hernández R; Gómez de Cedrón M; Tabernero M; Ramírez de Molina A; Lillo C; Medina JM; Tabernero A
    EBioMedicine; 2020 Dec; 62():103134. PubMed ID: 33254027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glioma stem cells and their non-stem differentiated glioma cells exhibit differences in mitochondrial structure and function.
    Kim EJ; Jin X; Kim OR; Ham SW; Park SH; Kim H
    Oncol Rep; 2018 Jan; 39(1):411-416. PubMed ID: 29115569
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GOT1-mediated anaplerotic glutamine metabolism regulates chronic acidosis stress in pancreatic cancer cells.
    Abrego J; Gunda V; Vernucci E; Shukla SK; King RJ; Dasgupta A; Goode G; Murthy D; Yu F; Singh PK
    Cancer Lett; 2017 Aug; 400():37-46. PubMed ID: 28455244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aberrant mesenchymal differentiation of glioma stem-like cells: implications for therapeutic targeting.
    Balasubramaniyan V; Vaillant B; Wang S; Gumin J; Butalid ME; Sai K; Mukheef F; Kim SH; Boddeke HW; Lang F; Aldape K; Sulman EP; Bhat KP; Colman H
    Oncotarget; 2015 Oct; 6(31):31007-17. PubMed ID: 26307681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Purine synthesis promotes maintenance of brain tumor initiating cells in glioma.
    Wang X; Yang K; Xie Q; Wu Q; Mack SC; Shi Y; Kim LJY; Prager BC; Flavahan WA; Liu X; Singer M; Hubert CG; Miller TE; Zhou W; Huang Z; Fang X; Regev A; Suvà ML; Hwang TH; Locasale JW; Bao S; Rich JN
    Nat Neurosci; 2017 May; 20(5):661-673. PubMed ID: 28346452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic regulation of glioma stem-like cells in the tumor micro-environment.
    Thomas TM; Yu JS
    Cancer Lett; 2017 Nov; 408():174-181. PubMed ID: 28743531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NT5DC2 promotes tumorigenicity of glioma stem-like cells by upregulating fyn.
    Guo S; Ran H; Xiao D; Huang H; Mi L; Wang X; Chen L; Li D; Zhang S; Han Q; Zhou T; Li A; Man J
    Cancer Lett; 2019 Jul; 454():98-107. PubMed ID: 30978441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Knockdown of nuclear factor erythroid 2-related factor 2 by lentivirus induces differentiation of glioma stem-like cells.
    Zhu J; Wang H; Fan Y; Hu Y; Ji X; Sun Q; Liu H
    Oncol Rep; 2014 Sep; 32(3):1170-8. PubMed ID: 25017049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autophagy-induced KDR/VEGFR-2 activation promotes the formation of vasculogenic mimicry by glioma stem cells.
    Wu HB; Yang S; Weng HY; Chen Q; Zhao XL; Fu WJ; Niu Q; Ping YF; Wang JM; Zhang X; Yao XH; Bian XW
    Autophagy; 2017 Sep; 13(9):1528-1542. PubMed ID: 28812437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two high-rate pentose-phosphate pathways in cancer cells.
    Cossu V; Bonanomi M; Bauckneht M; Ravera S; Righi N; Miceli A; Morbelli S; Orengo AM; Piccioli P; Bruno S; Gaglio D; Sambuceti G; Marini C
    Sci Rep; 2020 Dec; 10(1):22111. PubMed ID: 33335166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acidosis Acts through HSP90 in a PHD/VHL-Independent Manner to Promote HIF Function and Stem Cell Maintenance in Glioma.
    Filatova A; Seidel S; Böğürcü N; Gräf S; Garvalov BK; Acker T
    Cancer Res; 2016 Oct; 76(19):5845-5856. PubMed ID: 27488520
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nrf2-driven TERT regulates pentose phosphate pathway in glioblastoma.
    Ahmad F; Dixit D; Sharma V; Kumar A; Joshi SD; Sarkar C; Sen E
    Cell Death Dis; 2016 May; 7(5):e2213. PubMed ID: 27148686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel drug conjugate, NEO212, targeting proneural and mesenchymal subtypes of patient-derived glioma cancer stem cells.
    Jhaveri N; Agasse F; Armstrong D; Peng L; Commins D; Wang W; Rosenstein-Sisson R; Vaikari VP; Santiago SV; Santos T; Chen L; Schönthal AH; Chen TC; Hofman FM
    Cancer Lett; 2016 Feb; 371(2):240-50. PubMed ID: 26683773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Repurposing FDA approved drugs inhibiting mitochondrial function for targeting glioma-stem like cells.
    Datta S; Sears T; Cortopassi G; Woolard K; Angelastro JM
    Biomed Pharmacother; 2021 Jan; 133():111058. PubMed ID: 33378970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new 2-pyrone derivative, 5-bromo-3-(3-hydroxyprop-1-ynyl)-2H-pyran-2-one, suppresses stemness in glioma stem-like cells.
    Kim RK; Kim MJ; Yoon CH; Lim EJ; Yoo KC; Lee GH; Kim YH; Kim H; Jin YB; Lee YJ; Cho CG; Oh YS; Gye MC; Suh Y; Lee SJ
    Mol Pharmacol; 2012 Sep; 82(3):400-7. PubMed ID: 22648970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.